Treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage: Past, present, and future of hyperdynamic therapy

Neurosurgery Quarterly

Volumn 7, Issue 4, 1997, Pages 273-285

  Pritz, Michael B ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cardiac output; Hemodilution; Hyperdynamic therapy; Hypervolemia; Induced hypertension; Oxygen transport; Vasospasm

Indexed keywords

BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; HEART OUTPUT; HEMODILUTION; HUMAN; HYPERTENSION; HYPERVOLEMIA; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE;

EID: 0030834021     PISSN: 10506438     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013414-199712000-00004     Document Type: Review

References (76)

1. Allcock JM, Drake CG. Ruptured intracranial aneurysms: the role of arterial spasm. J Neurosurg 1965;22:21-9.
2. Kassell NF, Torner JC, Haley EC Jr., Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the timing of aneurysm surgery. I. Overall management results. J Neurosurg 1990;73:18-36.
3. Grubb RL Jr., Raichle ME, Eichung JO, Gado MH. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans. J Neurosurg 1977;46:446-53.
4. Montgomery EB Jr., Grubb RL Jr., Raichle ME. Cerebral hemodynamics and metabolism in postoperative cerebral vasospasm and treatment with hypertensive therapy. Ann Neurol 1981;9:502-6.
5. Yamakami I, Isobe K, Yamaura A, Nakamura T, Makino H. Vasospasm and regional cerebral blood flow (rCBF) in patients with ruptured intracranial aneurysm: serial rCBF studies with the xenon-133 inhalation method. Neurosurgery 1983;13:394-401.
6. 133Xe inhalation and emission computerized tomography. J Neurosurg 1984;60:916-22.
7. Rosenstein J, Suzuki M, Symon L, Redmond S. Clinical use of a portable bedside cerebral blood flow machine in the management of aneurysmal subarachnoid hemorrhage. Neurosurgery 1984;15: 519-25.
8. Davis S, Andrews J, Lichtenstein M, et al. A single-photon emission computed tomography study of hypoperfusion after subarachnoid hemorrhage. Stroke 1990;21:252-9.
9. Sundt TM Jr. Metabolic-cerebral blood flow couple. In: Sundt TM Jr, ed. Occlusive cerebrovascular disease: diagnosis and surgical management. Philadelphia: WB Saunders, 1987:3-10.
10. Pritz MB, Goldenberg TM. Usefulness of a fiber optic Swan-Ganz catheter to monitor oxygen transport during volume expansion in a patient with ischemic neurologic deficits from aneurysmal subarachnoid hemorrhage. Surg Neurol 1994;41:125-30.
11. Astrup J. Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy. J Neurosurg 1982;56:482-97.
12. Olsen TS, Larsen B, Heming M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue: evidence of an ischemic penumbra in patients with acute stroke. Stroke 1983;14:332-41.
13. Denny-Brown D. The treatment of recurrent cerebrovascular symptoms and the question of "vasospasm." Med Clin North Am 1951;35:1457-74.
14. Farhat SM, Schneider RC. Observations on the effect of systemic blood pressure on intracranial circulation in patients with cerebrovascular insufficiency. J Neurosurg 1967;27:441-5.
15. Keller TS, McGillicuddy JE, LaBond VA, Kindt GW. Volume expansion in focal cerebral ischemia: the effect of cardiac output on local cerebral blood flow. Clin Neurosurg 1982;29:40-50.
16. Muizelaar JP, Becker DP. Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage: direct effect on cerebral blood flow. Surg Neurol 1986;25:317-25.
17. Touho H, Ueda H. Disturbance of autoregulation in patients with ruptured intracranial aneurysms: mechanism of cortical and motor dysfunction. Surg Neurol 1994;42:57-64.
18. Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 1976;45:148-54.
19. Giannotta SL, McGillicuddy JE, Kindt GW. Diagnosis and treatment of postoperative cerebral vasospasm. Surg Neurol 1977;8: 286-90.
20. Maroon JC, Nelson PB. Hypovolemia in patients with subarachnoid hemorrhage: therapeutic implications. Neurosurgery 1979;4: 223-6.
21. Wijdicks EFM, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 1985;18:211-6.
22. Pritz MB, Giannotta SL, Kindt GW, McGillicuddy JE, Prager RL. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978;3:364-8.
23. Pritz MB. Monitoring cardiac function and intravascular volume in neurosurgical patients. Neurosurgery 1984;15:775-80.
24. Brown FD, Hanlon K, Mullan S. Treatment of aneurysmal hemiplegia with dopamine and mannitol. J Neurosurg 1978;49: 525-9.
25. Haraguchi S, Ebina K. Evaluation of the dopamine induced hypertension therapy for vasospasm [in Japanese]. Neurol Surg 1982; 10:279-89.
26. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337-43.
27. Levy WJ, Bay JW, Sawhny B, Tank T. Aminophylline plus nitroprusside and dopamine for treatment of cerebral vasospasm: a preliminary report. J Neurosurg 1982;56:646-9.
28. Tanabe T, Saitoh T, Tachibana S, Takagi H, Yada K. Effect of hyperdynamic therapy on cerebral ischaemia caused by vasospasm associated with subarachnoid haemorrhage. Acta Neurochir (Wien) 1982;63:291-6.
29. Pritz MB. Treatment of cerebral vasospasm: usefulness of SwanGanz catheter monitoring of volume expansion. Surg Neurol 1984; 21:239-44.
30. Finn SS, Stephensen SA, Miller CA, Drobnich L, Hunt WE. Observations on the perioperative management of aneurysmal subarachnoid hemorrhage. J Neurosurg 1986;65:48-62.
31. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FW Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18:365-72.
32. Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 1988;23: 699-704.
33. Hadeishi H, Mizuno M, Susuki A, Yasui N. Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo) 1990;30:317-23.
34. Otsubo H, Takemae T, Inoue T, Kobayashi S, Sugita K. Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 1990;103: 18-26.
35. Swift DM, Solomon RA. Unruptured aneurysms and postoperative volume expansion. J Neurosurg 1992;77:908-10.
36. Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 1993;79: 494-9.
37. Shimoda M, Oda S, Tsugane R, Sato O. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 1993;78:423-9.
38. Pritz MB, Zhou X-H, Brizendine EJ. Hyperdynamic therapy for cerebral vasospasm: a meta-analysis of 14 studies. J Neurovasc Dis 1996;1:6-8.
39. Davis DH, Sundt TM Jr. Relationship of cerebral blood flow to cardiac output, mean arterial pressure, blood volume, and alpha and beta blockade in cats. J Neurosurg 1980;52:745-54.
40. Giller CA, Levine BD, Meyer Y, Buckey JC, Lane LD, Borchers J. The cerebral hemodynamics of normotensive hypovolemia during lower-body negative pressure. J Neurosurg 1992;76:961-6.
41. Kudo T, Suzuki S, Iwabuchi T. Importance of monitoring the circulating blood volume in patients with cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1981;9:514-20.
42. Solomon RA, Post KD, McMurtry JG III. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 1984;15:354-61.
43. Diringer M, Wu KC, Verbalis JG, Hanley DF. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol 1992;31:543-50.
44. Vander Ark GD, Pomerantz M. Reversal of ischemic neurological signs by increasing the cardiac output. Surg Neurol 1973; 1:257-8.
45. Darby JM, Yonas H, Marks EC, Durham S, Snyder RW, Nemoto EM. Acute cerebral blood flow response to dopamine - induced hypertension after subarachnoid hemorrhage. J Neurosurg 1994; 80:857-64.
46. Eisenberg S. Cerebral circulatory effects of acutely induced hypervolemia in human subjects. Circ Res 1962;10:767-75.
47. Scheinberg P. Cerebral circulation in heart failure. Am J Med 1950; 8:148-52.
48. Pritz MB, Kindt GW. Transient neurologic deficits associated with congestive heart failure and hypovolemia. Surg Neurol 1981;15: 467-70.
49. Keller TS, McGillicuddy JE, LaBond VA, Kindt GW. Modifications of focal cerebral ischemia by cardiac output augmentation. J Surg Res 1985;39:420-32.
50. Tranmer BI, Keller TS, Kindt GW, Archer D. Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. J Neurosurg 1992;77:253-9.
51. Tranmer BI, Gross CE, Kindt GW, Adey GR. Pulsatile versus nonpulsatile blood flow in the treatment of acute cerebral ischemia. Neurosurgery 1986;19:724-31.
52. Yamikami I, Isobe K, Yamaura A. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms. Neurosurgery 1987;21:303-9.
53. Batjer H. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms [Comment]. Neurosurgery 1987;21:309.
54. Bouma GJ, Muizelaar JP. Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation. J Neurosurg 1990;73:368-74.
55. Solomon RA, Fink ME, Lennihan L. Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery: results of a preliminary trial. Arch Neurol 1988;45:325-32.
56. Coyne TJ, Wallace MC, Sinclair F. Pulmonary edema following prophylactic hypervolemia after subarachnoid hemorrhage [Abstract]. Stroke 1994;25:22.
57. Medlock MD, Dulebohn SC, Elwood PW. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992;30:12-6.
58. Pritz MB. Swan-Ganz catheter monitoring in neurosurgical patients: theoretical and practical aspects. Surg Neurol 1986;25:67-70.
59. Levy ML, Giannotta SL. Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991;75: 27-31.
60. Wood JH, Snyder LL, Simeone FA. Failure of intravascular volume expansion without hemodilution to elevate cortical blood flow in region of experimental focal ischemia. J Neurosurg 1982;56: 80-91.
61. Wood JH, Simeone FA, Fink EA, Golden MA. Hypervolemic hemodilution in experimental focal cerebral ischemia: elevation of cardiac output, regional cortical blood flow, and ICP after intravascular volume expansion with low molecular weight dextran. J Neurosurg 1983;59:500-9.
62. Korosue K, Heros RC. Mechanism of cerebral blood flow augmentation by hemodilution in rabbits. Stroke 1992;23:1487-93.
63. Thomas DJ, DuBoulay GH, Marshall J, et al. Effect of haematocrit on cerebral blood-flow in man. Lancet 1977;2:941-3.
64. Grotta J, Ackerman R, Correira J, Fallick G, Chang J. Whole blood viscosity parameters and cerebral blood flow. Stroke 1982;13:296-301.
65. Yamauchi H, Fukuyama H, Ogawa M, Ouchi Y, Kimura J. Hemodilution improves cerebral hemodynamics in internal carotid artery occlusion. Stroke 1993;24:1885-90.
66. Korosue K, Ishida K, Matsuoka H, Nagao T, Tamaki N, Matsumoto S. Clinical, hemodynamic, and hemorheological effects of isovolemic hemodilution in acute cerebral infarction. Neurosurgery 1988;23:148-53.
67. Wood JH, Kee DB Jr. Hemorheology of the cerebral circulation in stroke. Stroke 1985;16:765-72.
68. Heros RC, Korosue K. Hemodilution for cerebral ischemia. Stroke 1989;20:423-7.
69. Origitano TC, Wascher TH, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hyperten-sive hypervolemic hemodilution ("triple-H therapy") after subarachnoid hemorrhage. Neurosurgery 1990;27:729-40.
70. Brown MM, Wade JPH, Marshall J. Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain 1985;108:81-93.
71. Henriksen L, Paulson OB, Smith RJ. Cerebral blood flow following normovolemic hemodilution in patients with high hematocrit. Ann Neurol 1981;9:454-7.
72. Hino A, Ueda S, Mizukawa N, Imahori Y, Tenjin H. Effect of hemodilution on cerebral hemodynamics and oxygen metabolism. Stroke 1992;23:423-6.
73. Kusunoki M, Kimura K, Nakamura M, Isaka Y, Yoneda S, Abe H. Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease. J Cereb Blood Flow Metab 1981;1:413-7.
74. Gaehtgens P, Marx P. Hemorheological aspects of the pathophysiology of cerebral ischemia. J Cereb Blood Flow Metab 1987;7: 259-65.
75. Gur D, Wolfson SK Jr, Yonas H, et al. Progress in cerebrovascular disease: local cerebral blood flow by xenon enhanced CT. Stroke 1982;13:750-8.
76. Hino A, Mizukawa N, Tenjin H, et al. Postoperative hemodynamic and metabolic changes in patients with subarachnoid hemorrhage. Stroke 1989;20:1504-10.